Influence of clinical trials on current treatment strategy for Hodgkin's disease
- 31 July 1990
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 19 (1), 209-218
- https://doi.org/10.1016/0360-3016(90)90156-e
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- MOPP chemotherapy versus extended-field radiotherapy in the management of pathological stages I-IIA Hodgkin's disease.Journal of Clinical Oncology, 1989
- Alternating Non-Cross-Resistant Combination Chemotherapy or MOPP in Stage IV Hodgkin's DiseaseAnnals of Internal Medicine, 1986
- BCVPP Chemotherapy for Advanced Hodgkin's Disease: Evidence for Greater Duration of Complete Remission, Greater Survival, and Less Toxicity Than with a MOPP RegimenAnnals of Internal Medicine, 1984
- A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease.Journal of Clinical Oncology, 1984
- A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: A report from the Manchester lymphoma groupBritish Journal of Cancer, 1984
- An Additional Basic Science for Clinical Medicine: II. The Limitations of Randomized TrialsAnnals of Internal Medicine, 1983
- An Additional Basic Science for Clinical Medicine: I. The Constraining Fundamental ParadigmsAnnals of Internal Medicine, 1983
- Curability of Advanced Hodgkin's Disease with ChemotherapyAnnals of Internal Medicine, 1980
- Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerationsBlood, 1977
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975